Sands, J., Ahn, M., Lisberg, A., Cho, B. C., Blumenschein, G., Shum, E., Tostivint, E. P., Goto, Y., Yoh, K., Heist, R., Shimizu, J., Lee, J., Baas, P., Planchard, D., Pérol, M., Felip, E., Su, W., Zebger-Gong, H., Lan, L., Liu, C., Howarth, P., Chiaverelli, R., Paz-Ares, L. (2025). Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01349